BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15858960)

  • 1. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.
    Clayton PT; Eaton S; Aynsley-Green A; Edginton M; Hussain K; Krywawych S; Datta V; Malingre HE; Berger R; van den Berg IE
    J Clin Invest; 2001 Aug; 108(3):457-65. PubMed ID: 11489939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac phenotype in adolescents and young adults with long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD) deficiency.
    Elizondo G; Saini A; Gonzalez de Alba C; Gregor A; Harding CO; Gillingham MB; Vinocur JM
    Genet Med; 2024 Jun; 26(6):101123. PubMed ID: 38501492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis and genetic diagnosis of three children with Isoleucine metabolic disorders due to variants of HSD17B10 and ACAT1 genes].
    Ji W; Tian G; Zhang X; Wang Y; Yang Y; Zhou Z; Guo J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 May; 41(5):540-545. PubMed ID: 38684297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty Acid oxidation disorders in a chinese population in taiwan.
    Chien YH; Lee NC; Chao MC; Chen LC; Chen LH; Chien CC; Ho HC; Suen JH; Hwu WL
    JIMD Rep; 2013; 11():165-72. PubMed ID: 23700290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Autopsy Analysis of a Patient With Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Caused by Compound Heterozygous HADHA Gene Mutations.
    Zhang Q; Yao N; Liu Z; Xu C; Ding Z
    Am J Forensic Med Pathol; 2023 Dec; 44(4):336-339. PubMed ID: 37549033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated Free Fatty Acid Receptor 2 Exacerbates Colonic Adenoma Formation in
    Huang YW; Lin CW; Pan P; Echeveste CE; Dong A; Oshima K; Yearsley M; Yu J; Wang LS
    J Cancer Prev; 2021 Mar; 26(1):32-40. PubMed ID: 33842404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic Symptoms of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: A Report of Three Cases.
    Lange N; Bodetko AM; Mozrzymas R; Kowal-Lange A
    Case Rep Ophthalmol; 2024; 15(1):310-319. PubMed ID: 38595698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy.
    Gillingham MB; Choi D; Gregor A; Wongchaisuwat N; Black D; Scanga HL; Nischal KK; Sahel JA; Arnold G; Vockley J; Harding CO; Pennesi ME
    J Inherit Metab Dis; 2024 Apr; ():. PubMed ID: 38623632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms.
    Waisbren SE; Levy HL; Noble M; Matern D; Gregersen N; Pasley K; Marsden D
    Mol Genet Metab; 2008; 95(1-2):39-45. PubMed ID: 18676165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute fatty liver of pregnancy and neonatal long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency.
    Gutiérrez Junquera C; Balmaseda E; Gil E; Martínez A; Sorli M; Cuartero I; Merinero B; Ugarte M
    Eur J Pediatr; 2009 Jan; 168(1):103-6. PubMed ID: 18408953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long chain 3-hydroxyacyl-coA dehydrogenase deficiency, association with HELLP and magnetic resonance spectroscopy findings].
    Deltetto N; Maxit C; Marchione D; Szlago M; Schenone A; Besada CH; Vaccarezza M; Agosta G
    Arch Argent Pediatr; 2012 Aug; 110(4):e63-6. PubMed ID: 22859334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications.
    Strauss AW; Bennett MJ; Rinaldo P; Sims HF; O'Brien LK; Zhao Y; Gibson B; Ibdah J
    Semin Perinatol; 1999 Apr; 23(2):100-12. PubMed ID: 10331463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver disease in pregnancy and fetal fatty acid oxidation defects.
    Ibdah JA; Yang Z; Bennett MJ
    Mol Genet Metab; 2000; 71(1-2):182-9. PubMed ID: 11001809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
    Holub M; Bodamer OA; Item C; Mühl A; Pollak A; Stöckler-Ipsiroglu S
    Acta Paediatr; 2005 Jan; 94(1):48-52. PubMed ID: 15858960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease.
    Yang Z; Yamada J; Zhao Y; Strauss AW; Ibdah JA
    JAMA; 2002 Nov; 288(17):2163-6. PubMed ID: 12413376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
    Ibdah JA; Bennett MJ; Rinaldo P; Zhao Y; Gibson B; Sims HF; Strauss AW
    N Engl J Med; 1999 Jun; 340(22):1723-31. PubMed ID: 10352164
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.